Navigation Links
Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest
Date:3/16/2009

SEATTLE, March 17 /PRNewswire-FirstCall/ -- Craig Philips, President of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) will present at the 8th Annual WBBA Invest Northwest Conference on Wednesday, March 18th at 10:10 AM in the Harbor Dining Room of the Bell Harbor Conference Center.

Philips was named President of CTI in August of 2008. Prior to CTI, Philips was Vice President and General Manager of Bayer Healthcare Oncology, with direct responsibilities for all Development and Commercial Operations. Starting in 2006 Philips led Bayer's U.S. oncology operations, following the integration of the U.S. oncology businesses from Berlex and Bayer. He oversaw the U.S. oncology operations, with sales of $350 million and a staff of over 150. Prior to Bayer, Philips was the head of Berlex Oncology as Vice President and General Manager at Berlex Oncology. He was responsible for the U.S. oncology operations with sales of over $160 million. Prior to Berlex, Philips was with Schering Plough in U.S., global, and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, cardiology, and CNS.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at http://www.celltherapeutics.com.

                       WBBA Invest Northwest Conference
                 CTI Presentation: Wednesday, March 18, 2009
                     10:10 AM PST/1:10 PM EST/6:10 PM CET
              Harbor Dining Room, Bell Harbor Conference Center
            Audio webcast with slides at www.celltherapeutics.com

     Media Contact:
     Dan Eramian
     T: 206.272.4343
     C: 206.854.1200
     E: media@ctiseattle.com
     www.CellTherapeutics.com/press_room

     Investors Contact:
     Ed Bell
     T: 206.282.7100
     Lindsey Jesch Logan
     T: 206.272.4347
     F: 206.272.4434
     E: invest@ctiseattle.com
     www.CellTherapeutics.com/investors

'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
2. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
3. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
4. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
5. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
6. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
7. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
8. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
9. Zevalin Revenues Lead Cell Therapeutics, Inc.s First Quarter 2008 Financial Results
10. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
11. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... WASHINGTON, D.C., (PRWEB) , ... April 28, 2016 ... ... health systems, and the Campaign for Tobacco-Free Kids, a leading force in the ... to promote federal, state and local policies that can help reduce tobacco use. ...
(Date:4/28/2016)... NJ (PRWEB) , ... April 28, 2016 , ... ... BCBNSNJ), which is has been collaborating with doctors and hospitals to make transformative ... join the world’s leading cell therapy minds this week in discussing breakthroughs in ...
(Date:4/28/2016)... ... ... Amada Senior Care, premier provider of non-medical in-home care and assisted living ... West location. Prior to entering the senior care industry, Amada franchise partner Rick Stockton ... Antonio West will take place on Friday, April 29th. , Rick said ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the development of miniature microphones and headsets announced today that the US Patent ... of integrating in-earphones into a structure. This innovative design creates a lightweight and ...
(Date:4/28/2016)... , ... April 28, 2016 , ... Metabolic Nutrition ... GlycoLoad at this week’s 2016 Europa Games Get Fit and Sports Expo ... alike, the Europa Orlando Expo coming up April 29-30, was selected as the perfect ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: